Sunday July 23rd 2017

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Since 1993, eight different classes of disease-modifying therapies for relapsing-remitting multiple sclerosis (MS) have been developed and released to market. These drugs, to varying degrees, reduced the frequency of MS relapses, the accumulation of lesions on MRI, and the progression of disability in randomised controlled trials with follow-up of 2–3 years. The first generation of treatments, beta interferons and glatiramer acetate, also delay a second relapse and thus the risk of conversion to clinically definite MS in patients with a first clinical demyelinating event. (Source: Lancet Neurology)

Continue reading:  

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Leave a Comment

More from category

Mothers who breastfeed might have lower multiple sclerosis risk
Mothers who breastfeed might have lower multiple sclerosis risk

(Reuters Health) - Women who breastfeed may have a lower risk of developing multiple sclerosis later in life compared [Read More]

Lipoic acid in nutritional supplements found to help prevent multiple sclerosis, study finds
Lipoic acid in nutritional supplements found to help prevent multiple sclerosis, study finds

(Natural News) The results of a new pilot study showed the efficacy of lipoic acid in the reduction of whole brain [Read More]

Multiple sclerosis symptoms: Immune system problems can trigger PARALYSIS of the legs
Multiple sclerosis symptoms: Immune system problems can trigger PARALYSIS of the legs

MULTIPLE sclerosis - commonly abbreviated to MS - is a type of autoimmune disease which can cause problems with vision, [Read More]

National Patient-Advocacy Organizations Oppose ACA Repeal
National Patient-Advocacy Organizations Oppose ACA Repeal

/About-the-Society/News/National-Patient-Advocacy-Organizations-Oppose-ACA [Read More]

Exclusive: Nurses reluctant to discuss disability with MS patients
Exclusive: Nurses reluctant to discuss disability with MS patients

Nearly two-thirds of specialist nurses are reluctant to discuss disability with patients who have multiple sclerosis, [Read More]